āagman

Not investment advice. Data and computed figures, for information only.

Supriya Lifescience Ltd

NSE: SUPRIYA
₹872.60
−₹1.95 (−0.22%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹6,822 Cr
CMP
₹872.60
52-wk High / Low
₹1,085 / 546
P/E
34.3
P/B
5.7
Book Value
₹149.0
Div Yield
0.12%
ROCE
25.0%
ROE
19.1%
Face Value
₹2
D/E
0.00

Price+20.9% over 1Y

āagman read

Computed by āagman
Derived from 10 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
3
/ 9
3 of 9 F-score tests passed
Graham Number
₹295
√(22.5 × EPS × book value per share)
ROIC
16.9%
vs 11.2% sector median
Cash flow to profit
0.89
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−1,113
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
18.3%
ROE × earnings retention ratio
ROE stability
4.1
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +1.02DII −0.40
Latest quarter vs the previous one
Cash-accrual divergence
1.9%
of assets
Low = accruals track cash flow
Strengths
+ROCE has stayed above the sector median for 5 consecutive years (weakest: 19% vs the 2023 sector median of 17.5%)
+Price trades above its 200-day moving average (1.1x)
+FII holding rose by 0.5pp over the last year
+PE of 34.3x is below the sector median of 45.9x
Watch-outs
−Annualised volatility of 47.5% is in the high band (≥45%)
−Piotroski F-Score of 3/9 is in the weak band (≤3)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Standalone basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales132140140158161166186184145200206277190
Expenses88108991039810112011793127134179142
Operating Profit44324156636566685273729847
OPM %33.3%22.9%29.3%35.4%39.1%39.2%35.5%37.0%35.9%36.5%35.0%35.4%24.7%
Other Income3232232333233
Interest1001001010000
Depreciation4444555667789
Profit before tax43304053606263644768679241
Net Profit29243037454647503550507424
EPS (₹)3.542.973.704.595.555.735.816.264.326.276.179.222.99

Profit & Loss

As of 30 Jun 2026
Standalone · ₹ Cr · 10 years + TTM
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales184213278312391530461570696828873
Expenses166191213213218316332394436533583
Operating Profit17226598173214129176261295290
OPM %9.2%10.3%23.4%31.4%44.2%40.4%28.0%30.9%37.5%35.6%33.2%
Other Income7981158911101111
Interest12111074435232
Depreciation55567101216202831
Profit before tax8145796167207123166248275268
Net Profit69397312415290119188209198
EPS (₹)3.875.9626.9350.1116.8918.8611.1714.8023.3525.9824.65

Balance Sheet

As of 30 Jun 2026
Standalone · ₹ Cr
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital15151515151616161616—
Reserves3140791342546006837999811,182—
Borrowings1401309082722722555—
Other Liabilities5560691051059298101115154—
Total Liabilities2412452533364457358209211,1171,357—
Fixed Assets89918599100190262310453689—
CWIP3634354079436814914836—
Investments00000025646399—
Other Assets117120133197267502466399453534—
Total Assets2412452533364457358209211,1171,357—

Cash Flows

As of 31 Mar 2026
Standalone · ₹ Cr
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity272849117764964113165186
Cash from Investing Activity−27−55−25−47−60−124−174−152−176
Cash from Financing Activity−2−20−50−29−15150−10−22−8−10
Net Cash Flow−2346215139−70−8340

Ratios

As of 31 Mar 2026
10 periods
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—14.037.050.060.043.019.022.027.025.0
ROE %—————————19.1
EPS (₹)3.875.9626.9350.1116.8918.8611.1714.8023.3525.98
Book Value (₹)—————————149.0
Face Value (₹)—————————2
P/E—————————34.3
Div Yield %—————————0.12
NPM %3.14.113.622.631.328.319.120.526.624.9
OPM %9.010.023.032.044.040.028.031.037.036.0
D/E3.042.360.960.550.270.040.030.010.010.00
P/B—————————5.7

Growth

As of 11 Oct 2026
Compounded sales growth
5 years+16.0%
3 years+22.0%
TTM+28.0%
Compounded profit growth
5 years+11.0%
3 years+32.0%
TTM+12.0%
Stock price CAGR
3 years+50.0%
Last year+17.0%
Return on equity
10 years23.0%
5 years20.0%
3 years19.0%
Last year19.0%

Shareholding pattern

As of 31 Dec 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters68.24%68.24%68.28%68.30%68.30%68.30%68.30%
FIIs7.13%7.13%5.66%5.37%7.19%5.16%6.18%
DIIs7.73%7.73%7.65%5.30%4.26%5.70%5.30%
Government———————
Public16.90%16.90%18.43%21.04%20.25%20.83%20.21%
No. of shareholders82,57882,57895,60587,98091,05181,16182,082
Change since Jun 2023 (pp)
Promoters +0.06FIIs −0.95DIIs −2.43Public +3.31

Documents

As of 11 Oct 2026
Announcements
Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015.Closure of Trading WindowShareholder Meeting / Postal Ballot-Outcome of AGMShareholder Meeting / Postal Ballot-Scrutinizer''s ReportAnnouncement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTNov 2025TranscriptNov 2025PPTNov 2025RecordingAug 2025TranscriptAug 2025PPTAug 2025Recording

Corporate actions

As of 4 Sep 2026
4 Sep 2026DIVIDENDDividend - Re 1 Per Share—
4 Sep 2025DIVIDENDDividend - Re 1 Per Share—
20 Sep 2024DIVIDENDAnnual General Meeting/Dividend - Rs 0.80 Per Share—
15 Sep 2023DIVIDENDAnnual General Meeting/Dividend - Re 0.60 Per Share—
1 Sep 2022DIVIDENDAnnual General Meeting/Dividend - Re 0.60 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman